SCHEMBL17855952

SCHEMBL17855952

CCN(CC)c1ccc2c(c1)-c1ccccc1C2(c1ccccc1)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.45
▸ MEN1 O00255 6/20 0.45
▸ KMT2A Q03164 6/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ KDM4E B2RXH2 3/20 0.45
▸ LMNA P02545 2/20 0.45
▸ OPRK1 P41145 1/20 0.45
▸ MAPK1 P28482 3/20 0.41
▸ GAA P10253 3/20 0.41
▸ HTT P42858 1/20 0.41
▸ ALDH1A1 P00352 6/20 0.39
▸ L3MBTL1 Q9Y468 5/20 0.39
▸ HPGD P15428 2/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ ESR1 P03372 1/20 0.39
▸ ESR2 Q92731 1/20 0.39
▸ CNR2 P34972 1/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ CYP3A4 P08684 2/20 0.37
▸ PSMD14 O00487 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17903058 0.91 PDK2 (0.42) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL17903075 0.89 MEN1 (0.49) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL17855430 0.89 MEN1 (0.41) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL19447686 0.84 ALDH1A1 (0.46) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL22177143 0.83 MEN1 (0.49) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL20707407 0.83 MEN1 (0.49) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL17903114 0.83 MEN1 (0.53) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL17854470 0.82 MEN1 (0.52) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL17903101 0.81 MEN1 (0.51) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL25563682 0.81 MEN1 (0.47) MAPTMEN1KMT2ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160181525-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160181525-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ESR1, ESR2, CCNE2 MAPT 1923/4885MEN1 782/4885KMT2A 917/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback